Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Radiochemotherapy with cisplatin and oral tegafur in advanced head and neck cancer: long-term results of a phase II study.

de la Torre A, Romero J, Montero A, Garcia-Berrocal MI, Valcarcel FJ, Cordoba S, Magallon R.

Tumori. 2008 Jul-Aug;94(4):453-8.

PMID:
18822677
2.

Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.

Wibault P, Bensmaine MA, de Forni M, Armand JP, Tellez Bernal E, Guillot T, Recondo G, Domenge C, Janot F, Borel C, Luboinski B, Eschwege F, Cvitkovic E.

J Clin Oncol. 1996 Apr;14(4):1192-200.

PMID:
8648374
3.

Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.

Fesneau M, Pointreau Y, Chapet S, Martin L, Pommier P, Alfonsi M, Laguerre B, Feham N, Berger C, Garaud P, Calais G.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):154-63. doi: 10.1016/j.ijrobp.2009.01.033.

PMID:
19386430
4.

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

Merlano M, Benasso M, Corvò R, Rosso R, Vitale V, Blengio F, Numico G, Margarino G, Bonelli L, Santi L.

J Natl Cancer Inst. 1996 May 1;88(9):583-9.

PMID:
8609658
5.
6.

Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.

Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.

Cancer Chemother Pharmacol. 2008 Dec;63(1):9-17. doi: 10.1007/s00280-008-0702-1. Epub 2008 Mar 15.

PMID:
18343925
7.

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.

Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS.

J Clin Oncol. 2006 Sep 1;24(25):4163-9.

PMID:
16943532
8.

[SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].

Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A.

Otolaryngol Pol. 2011 Sep;65(5 Suppl):117-25. Polish.

PMID:
22000261
9.

Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.

Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.

Oral Oncol. 2006 Aug;42(7):675-84. Epub 2006 May 30.

PMID:
16731029
10.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
12.
13.

[Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept].

Dietz A, Rudat V, Nollert J, Flentje M, Maiei H, Wannenmacher M, Weidauer H.

Laryngorhinootologie. 1996 Dec;75(12):745-53. German.

PMID:
9081280
14.

Radiochemotherapy with cisplatin and oral tegafur in advanced head and neck cancer: long-term results of a phase II study.

Kanatas A, Mitchell D.

Tumori. 2009 Mar-Apr;95(2):269; author reply 269-70. No abstract available.

PMID:
19579881
15.

Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.

Aguilar-Ponce JL, Granados-García M, Cruz López JC, Maldonado-Magos F, Alvarez-Avitia MA, Arrieta O, González-Ramírez I, Lara-Cruz G, Martinez-Juárez I, Medina-Santillan R, Castillo-Hernández C, De la Garza-Salazar J.

Oral Oncol. 2013 Mar;49(3):249-54. doi: 10.1016/j.oraloncology.2012.09.008. Epub 2012 Oct 6.

PMID:
23043985
16.

Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.

Tribius S, Kronemann S, Kilic Y, Schroeder U, Hakim S, Schild SE, Rades D.

Strahlenther Onkol. 2009 Oct;185(10):675-81. doi: 10.1007/s00066-009-1992-x. Epub 2009 Oct 6.

PMID:
19806333
17.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.

J Clin Oncol. 2004 Aug 1;22(15):3061-9.

PMID:
15284256
18.

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.

Pfister DG, Su YB, Kraus DH, Wolden SL, Lis E, Aliff TB, Zahalsky AJ, Lake S, Needle MN, Shaha AR, Shah JP, Zelefsky MJ.

J Clin Oncol. 2006 Mar 1;24(7):1072-8.

PMID:
16505426
19.

Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.

González-Larriba JL, Garcia Carbonero I, Sastre Valera J, Perez Segura P, Diaz-Rubio E.

Oncology (Williston Park). 1997 Sep;11(9 Suppl 10):90-7.

Supplemental Content

Support Center